imiquimod has been researched along with Orphan Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dang, Y; Geng, S; Guo, Y; Toyohara, JP | 1 |
| Caglia, M; Hashemi, P; Kim, C; Shulman, K | 1 |
| Chen, O; Corley, SB; Morrell, DS; Pearlstein, MV | 1 |
3 other study(ies) available for imiquimod and Orphan Diseases
| Article | Year |
|---|---|
Successful treatment of verruciform xanthoma with imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Biopsy, Needle; Child, Preschool; Female; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Rare Diseases; Skin Diseases; Time Factors; Treatment Outcome; Vulvar Diseases; Xanthomatosis | 2013 |
Treatment of Imiquimod Resistant Epidermodysplasia Verruciformis With Ingenol Mebutate.
Topics: Acitretin; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diterpenes; Drug Resistance; Epidermodysplasia Verruciformis; Female; Gels; Humans; Imiquimod; Keratolytic Agents; Rare Diseases; Skin Neoplasms; Treatment Outcome; Tretinoin | 2016 |
Verrucae Planae Within Previous Xenograft Sites of Burn Wounds.
Topics: Administration, Topical; Aminoquinolines; Burns; Child, Preschool; Follow-Up Studies; Heterografts; Humans; Imiquimod; Immunocompromised Host; Injury Severity Score; Male; Rare Diseases; Severity of Illness Index; Skin Diseases; Skin Transplantation; Treatment Outcome; Warts | 2017 |